Patent application number | Description | Published |
20080275830 | Annotating audio-visual data - A method of annotating audio-visual data is disclosed. The method includes detecting a plurality of facial expressions in an audience based on a stimulus, determining an emotional response to the stimulus based on the facial expressions and generating at least one annotation of the stimulus based on the determined emotional response. | 11-06-2008 |
20090019472 | Systems and methods for pricing advertising - A system for pricing advertising includes an electronic video display disposed in an advertising venue, wherein the display is configured to display advertising; a sensor configured to sense a number of people in an audience of the electronic video display; and a processing element for determining pricing for the advertising. The pricing for the advertising is determined based on the number of people in the audience. A method of pricing advertising, the method includes determining a number of people in an audience of an electronic video display disposed at an advertising venue on which the advertising is displayed; and determining pricing of the advertising based on the number of people in the audience. | 01-15-2009 |
20090037945 | MULTIMEDIA PRESENTATION APPARATUS, METHOD OF SELECTING MULTIMEDIA CONTENT, AND COMPUTER PROGRAM PRODUCT - Provided is a multimedia presentation apparatus comprising:
| 02-05-2009 |
20100008549 | Increasing Face Detection Speed - Systems, methods, and other embodiments associated with increasing face detection speed are described. One example method includes determining whether to control a face detection process to selectively perform a face detection in a patch in a digital image. The face detection may be based, at least in part, on determining whether the patch overlaps a face previously identified by the face detection process. The example method may also include providing a signal to control the face detection process to perform the face detection upon determining that a patch overlap does not exceed an overlap factor. | 01-14-2010 |
20110044545 | SYSTEMS AND METHODS TO INCREASE SPEED OF OBJECT DETECTION IN A DIGITAL IMAGE - Systems and methods are disclosed that determine a largest patch size to traverse a digital image, analyze the digital image to detect one or more first objects of a size approximately the same as the largest patch size, and discontinue analyzing the digital image when the digital image includes the first object(s) of a size approximately the same as the largest patch size. The patch size is decremented to progressively smaller patch sizes if the first object(s) of a size approximately the same as the largest patch size is not detected and the digital image is further analyzed to detect one or more first objects of a size approximately the same as the smaller patch size until the first object(s) are detected or the patch size is decremented below a predetermined smallest size. | 02-24-2011 |
20110285748 | Dynamic Image Collage - A sequence of templates ( | 11-24-2011 |
20120106848 | System And Method For Assessing Photgrapher Competence - A method for automatically assessing the competence of a photographer includes assigning a competency level to the photographer based on a statistical comparison of image features between a collection of the photographer's images and a collection of high competency images. Service and product offerings can be tailored to the photographer based on the competency level assigned by the statistical comparison. | 05-03-2012 |
20120192047 | SYSTEMS AND METHODS FOR BUILDING COMPLEX DOCUMENTS - Systems and methods are provided for building a complex document. A system can include a memory for storing computer executable instructions and a processing unit for accessing the memory and executing the computer executable instructions. The computer executable instructions can include a graphical user interface engine to display a target complex document browser and a plurality of source complex document browsers, such that elements and containers contained within a complex document displayed by each of the source complex document browsers are copyable into the target complex document browser in response to user input information to build a new complex document. | 07-26-2012 |
20120192092 | SYSTEMS AND METHODS FOR BUILDING COMPLEX DOCUMENTS EMPLOYING FEEDFORWARD INDICATORS - Systems and methods are provided for building a complex document. A system can include a memory for storing computer executable instructions and a processing unit for accessing the memory and executing the computer executable instructions. The computer executable instructions can include a graphical user interface engine to display a complex document and to display a feedforward indicator associated with an element in the complex document in response to a first user operation. The feedforward indicator provides a user with an indication of affects to the complex document associated with a second user operation. | 07-26-2012 |
20140013214 | Method and System of Populating a Space - The present invention relates to a method of populating a space | 01-09-2014 |
Patent application number | Description | Published |
20100022611 | 1,5-Diaryl-Pyrazoles As Cannabinoid Receptor Neutral Antagonists Useful As Therapeutic Agents - The present invention pertains to cannabinoid (CB) receptor neutral antagonists, and especially CB1 neutral antagonists, and including, for example, certain | 01-28-2010 |
20110172189 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. Formula (I). | 07-14-2011 |
20110190302 | Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 08-04-2011 |
Patent application number | Description | Published |
20080221220 | 2',4'-DICHLORO-BIPHENYL-4-YL-HYDROXY-KETONES AND RELATED COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain 2′,4′-dichloro-biphenyl-4-yl-hydroxy-ketones and related compounds (collectively referred to herein as “DCBP compounds”), and more particularly to compounds selected from compounds of the following formula and pharmaceutically acceptable salts, solvates, and hydrates thereof: | 09-11-2008 |
20100286266 | Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl sulfonamides and related compounds (collectively referred to herein as ‘BPSAAA compounds’), as described herein, and including, for example, biphenyl-4-sulfonic acid (hydroxyalkyl-phenyl)-amides and related compounds. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment and/or prevention, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of, inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activation in rheumatoid arthritis, osteoporosis, cancer associated bone disease, Paget's disease and the like. | 11-11-2010 |
20130245018 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 09-19-2013 |
20150141472 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 05-21-2015 |
20150266815 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 09-24-2015 |